BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hollander JA, Lu Q, Cameron MD, Kamenecka TM, Kenny PJ. Insular hypocretin transmission regulates nicotine reward. Proc Natl Acad Sci U S A 2008;105:19480-5. [PMID: 19033203 DOI: 10.1073/pnas.0808023105] [Cited by in Crossref: 196] [Cited by in F6Publishing: 195] [Article Influence: 14.0] [Reference Citation Analysis]
Number Citing Articles
1 Quarta D, Smolders I. Rewarding, reinforcing and incentive salient events involve orexigenic hypothalamic neuropeptides regulating mesolimbic dopaminergic neurotransmission. European Journal of Pharmaceutical Sciences 2014;57:2-10. [DOI: 10.1016/j.ejps.2014.01.008] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 3.5] [Reference Citation Analysis]
2 Benowitz NL. Nicotine addiction. N Engl J Med. 2010;362:2295-2303. [PMID: 20554984 DOI: 10.1056/nejmra0809890] [Cited by in Crossref: 766] [Cited by in F6Publishing: 417] [Article Influence: 63.8] [Reference Citation Analysis]
3 Brown RM, Lawrence AJ. Ascending orexinergic pathways and alcohol-seeking. Curr Opin Neurobiol 2013;23:467-72. [PMID: 23537903 DOI: 10.1016/j.conb.2013.02.014] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
4 van Holst RJ, van der Cruijsen L, van Mierlo P, Lammers GJ, Cools R, Overeem S, Aarts E. Aberrant Food Choices after Satiation in Human Orexin-Deficient Narcolepsy Type 1. Sleep 2016;39:1951-9. [PMID: 27568806 DOI: 10.5665/sleep.6222] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]
5 Schmidt HD, Rupprecht LE, Addy NA. Neurobiological and Neurophysiological Mechanisms Underlying Nicotine Seeking and Smoking Relapse. Mol Neuropsychiatry 2019;4:169-89. [PMID: 30815453 DOI: 10.1159/000494799] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
6 Khoo SY, McNally GP, Clemens KJ. The dual orexin receptor antagonist TCS1102 does not affect reinstatement of nicotine-seeking. PLoS One 2017;12:e0173967. [PMID: 28296947 DOI: 10.1371/journal.pone.0173967] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
7 Perrey DA, German NA, Gilmour BP, Li JX, Harris DL, Thomas BF, Zhang Y. Substituted tetrahydroisoquinolines as selective antagonists for the orexin 1 receptor. J Med Chem 2013;56:6901-16. [PMID: 23941044 DOI: 10.1021/jm400720h] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 3.2] [Reference Citation Analysis]
8 Fadel J, Burk JA. Orexin/hypocretin modulation of the basal forebrain cholinergic system: Role in attention. Brain Res 2010;1314:112-23. [PMID: 19699722 DOI: 10.1016/j.brainres.2009.08.046] [Cited by in Crossref: 56] [Cited by in F6Publishing: 58] [Article Influence: 4.3] [Reference Citation Analysis]
9 Di Sebastiano AR, Wilson-pérez HE, Lehman MN, Coolen LM. Lesions of orexin neurons block conditioned place preference for sexual behavior in male rats. Hormones and Behavior 2011;59:1-8. [DOI: 10.1016/j.yhbeh.2010.09.006] [Cited by in Crossref: 37] [Cited by in F6Publishing: 28] [Article Influence: 3.4] [Reference Citation Analysis]
10 Tyree SM, Borniger JC, de Lecea L. Hypocretin as a Hub for Arousal and Motivation. Front Neurol 2018;9:413. [PMID: 29928253 DOI: 10.3389/fneur.2018.00413] [Cited by in Crossref: 37] [Cited by in F6Publishing: 28] [Article Influence: 9.3] [Reference Citation Analysis]
11 Kenny PJ. Common cellular and molecular mechanisms in obesity and drug addiction. Nat Rev Neurosci. 2011;12:638-651. [PMID: 22011680 DOI: 10.1038/nrn3105] [Cited by in Crossref: 237] [Cited by in F6Publishing: 227] [Article Influence: 21.5] [Reference Citation Analysis]
12 Hollander JA, Pham D, Fowler CD, Kenny PJ. Hypocretin-1 receptors regulate the reinforcing and reward-enhancing effects of cocaine: pharmacological and behavioral genetics evidence. Front Behav Neurosci 2012;6:47. [PMID: 22837742 DOI: 10.3389/fnbeh.2012.00047] [Cited by in Crossref: 56] [Cited by in F6Publishing: 56] [Article Influence: 5.6] [Reference Citation Analysis]
13 Mahler SV, Smith RJ, Moorman DE, Sartor GC, Aston-Jones G. Multiple roles for orexin/hypocretin in addiction. Prog Brain Res 2012;198:79-121. [PMID: 22813971 DOI: 10.1016/B978-0-444-59489-1.00007-0] [Cited by in Crossref: 140] [Cited by in F6Publishing: 76] [Article Influence: 14.0] [Reference Citation Analysis]
14 Stojakovic A, Espinosa EP, Farhad OT, Lutfy K. Effects of nicotine on homeostatic and hedonic components of food intake. J Endocrinol 2017;235:R13-31. [PMID: 28814527 DOI: 10.1530/JOE-17-0166] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 4.4] [Reference Citation Analysis]
15 Cason AM, Smith RJ, Tahsili-Fahadan P, Moorman DE, Sartor GC, Aston-Jones G. Role of orexin/hypocretin in reward-seeking and addiction: implications for obesity. Physiol Behav 2010;100:419-28. [PMID: 20338186 DOI: 10.1016/j.physbeh.2010.03.009] [Cited by in Crossref: 155] [Cited by in F6Publishing: 150] [Article Influence: 12.9] [Reference Citation Analysis]
16 Baimel C, Bartlett SE, Chiou LC, Lawrence AJ, Muschamp JW, Patkar O, Tung LW, Borgland SL. Orexin/hypocretin role in reward: implications for opioid and other addictions. Br J Pharmacol 2015;172:334-48. [PMID: 24641197 DOI: 10.1111/bph.12639] [Cited by in Crossref: 97] [Cited by in F6Publishing: 92] [Article Influence: 12.1] [Reference Citation Analysis]
17 Lopez MF, Moorman DE, Aston-Jones G, Becker HC. The highly selective orexin/hypocretin 1 receptor antagonist GSK1059865 potently reduces ethanol drinking in ethanol dependent mice. Brain Res 2016;1636:74-80. [PMID: 26851547 DOI: 10.1016/j.brainres.2016.01.049] [Cited by in Crossref: 42] [Cited by in F6Publishing: 35] [Article Influence: 7.0] [Reference Citation Analysis]
18 Boutrel B, Cannella N, de Lecea L. The role of hypocretin in driving arousal and goal-oriented behaviors. Brain Res 2010;1314:103-11. [PMID: 19948148 DOI: 10.1016/j.brainres.2009.11.054] [Cited by in Crossref: 84] [Cited by in F6Publishing: 86] [Article Influence: 6.5] [Reference Citation Analysis]
19 Zhang H, Lian Z, Yan S, Bao Y, Liu Z. Different levels in orexin concentrations and risk factors associated with higher orexin levels: comparison between detoxified opiate and methamphetamine addicts in 5 Chinese cities. Biomed Res Int 2013;2013:282641. [PMID: 24102051 DOI: 10.1155/2013/282641] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
20 Fowler CD, Kenny PJ. Intravenous nicotine self-administration and cue-induced reinstatement in mice: effects of nicotine dose, rate of drug infusion and prior instrumental training. Neuropharmacology 2011;61:687-98. [PMID: 21640128 DOI: 10.1016/j.neuropharm.2011.05.012] [Cited by in Crossref: 46] [Cited by in F6Publishing: 49] [Article Influence: 4.2] [Reference Citation Analysis]
21 Subramaniyan M, Dani JA. Dopaminergic and cholinergic learning mechanisms in nicotine addiction. Ann N Y Acad Sci 2015;1349:46-63. [PMID: 26301866 DOI: 10.1111/nyas.12871] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 6.1] [Reference Citation Analysis]
22 Cifani C, Di Bonaventura MVM, Ciccocioppo R, Massi M. Binge Eating in Female Rats Induced by Yo-Yo Dieting and Stress. In: Avena NM, editor. Animal Models of Eating Disorders. Totowa: Humana Press; 2013. pp. 27-49. [DOI: 10.1007/978-1-62703-104-2_3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
23 Pushparaj A, Kim AS, Musiol M, Trigo JM, Le Foll B. Involvement of the rostral agranular insular cortex in nicotine self-administration in rats. Behav Brain Res 2015;290:77-83. [PMID: 25934486 DOI: 10.1016/j.bbr.2015.04.039] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
24 Yeoh JW, Campbell EJ, James MH, Graham BA, Dayas CV. Orexin antagonists for neuropsychiatric disease: progress and potential pitfalls. Front Neurosci 2014;8:36. [PMID: 24616658 DOI: 10.3389/fnins.2014.00036] [Cited by in Crossref: 59] [Cited by in F6Publishing: 59] [Article Influence: 7.4] [Reference Citation Analysis]
25 Francesconi W, Berton F, Koob GF, Sanna PP. Intrinsic neuronal plasticity in the juxtacapsular nucleus of the bed nuclei of the stria terminalis (jcBNST). Prog Neuropsychopharmacol Biol Psychiatry 2009;33:1347-55. [PMID: 19683025 DOI: 10.1016/j.pnpbp.2009.08.003] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
26 al'Absi M, Lemieux A, Nakajima M, Hatsukami DK, Allen S. Circulating leptin and pain perception among tobacco-dependent individuals. Biol Psychol 2015;107:10-5. [PMID: 25720946 DOI: 10.1016/j.biopsycho.2015.02.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
27 Harmey D, Griffin PR, Kenny PJ. Development of novel pharmacotherapeutics for tobacco dependence: progress and future directions. Nicotine Tob Res 2012;14:1300-18. [PMID: 23024249 DOI: 10.1093/ntr/nts201] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
28 Fartootzadeh R, Azizi F, Alaei H, Reisi P. Orexin type-2 receptor blockade prevents the nicotine-induced excitation of nucleus accumbens core neurons in rats: An electrophysiological perspective. Pharmacol Rep 2019;71:361-6. [PMID: 30831442 DOI: 10.1016/j.pharep.2018.12.013] [Reference Citation Analysis]
29 Berridge CW, España RA, Vittoz NM. Hypocretin/orexin in arousal and stress. Brain Res 2010;1314:91-102. [PMID: 19748490 DOI: 10.1016/j.brainres.2009.09.019] [Cited by in Crossref: 115] [Cited by in F6Publishing: 115] [Article Influence: 8.8] [Reference Citation Analysis]
30 Prince CD, Rau AR, Yorgason JT, España RA. Hypocretin/Orexin regulation of dopamine signaling and cocaine self-administration is mediated predominantly by hypocretin receptor 1. ACS Chem Neurosci 2015;6:138-46. [PMID: 25496218 DOI: 10.1021/cn500246j] [Cited by in Crossref: 55] [Cited by in F6Publishing: 48] [Article Influence: 6.9] [Reference Citation Analysis]
31 Ubaldi M, Cannella N, Ciccocioppo R. Emerging targets for addiction neuropharmacology: From mechanisms to therapeutics. Prog Brain Res 2016;224:251-84. [PMID: 26822362 DOI: 10.1016/bs.pbr.2015.07.018] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
32 Qi X, Astle J, Kodadek T. Rapid identification of orexin receptor binding ligands using cell-based screening accelerated with magnetic beads. Mol Biosyst 2010;6:102-7. [PMID: 20024071 DOI: 10.1039/b915611a] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
33 Chang GQ, Karatayev O, Leibowitz SF. Prenatal exposure to nicotine stimulates neurogenesis of orexigenic peptide-expressing neurons in hypothalamus and amygdala. J Neurosci 2013;33:13600-11. [PMID: 23966683 DOI: 10.1523/JNEUROSCI.5835-12.2013] [Cited by in Crossref: 29] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
34 Mihindou C, Vouillac C, Koob GF, Ahmed SH. Preclinical validation of a novel cocaine exposure therapy for relapse prevention. Biol Psychiatry 2011;70:593-8. [PMID: 21571256 DOI: 10.1016/j.biopsych.2011.03.036] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
35 Bruijnzeel AW. Tobacco addiction and the dysregulation of brain stress systems. Neurosci Biobehav Rev 2012;36:1418-41. [PMID: 22405889 DOI: 10.1016/j.neubiorev.2012.02.015] [Cited by in Crossref: 100] [Cited by in F6Publishing: 92] [Article Influence: 10.0] [Reference Citation Analysis]
36 Huang Y, Kakusa BW, Feng A, Gattas S, Shivacharan RS, Lee EB, Parker JJ, Kuijper FM, Barbosa DAN, Keller CJ, Bohon C, Mikhail A, Halpern CH. The insulo-opercular cortex encodes food-specific content under controlled and naturalistic conditions. Nat Commun 2021;12:3609. [PMID: 34127675 DOI: 10.1038/s41467-021-23885-4] [Reference Citation Analysis]
37 Graebner AK, Iyer M, Carter ME. Understanding how discrete populations of hypothalamic neurons orchestrate complicated behavioral states. Front Syst Neurosci 2015;9:111. [PMID: 26300745 DOI: 10.3389/fnsys.2015.00111] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
38 Kenny PJ. Tobacco dependence, the insular cortex and the hypocretin connection. Pharmacol Biochem Behav 2011;97:700-7. [PMID: 20816891 DOI: 10.1016/j.pbb.2010.08.015] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 3.2] [Reference Citation Analysis]
39 Khani A, Rainer G. Neural and neurochemical basis of reinforcement-guided decision making. J Neurophysiol 2016;116:724-41. [PMID: 27226454 DOI: 10.1152/jn.01113.2015] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
40 Bruijnzeel AW, Alexander JC, Perez PD, Bauzo-Rodriguez R, Hall G, Klausner R, Guerra V, Zeng H, Igari M, Febo M. Acute nicotine administration increases BOLD fMRI signal in brain regions involved in reward signaling and compulsive drug intake in rats. Int J Neuropsychopharmacol 2014;18:pyu011. [PMID: 25552431 DOI: 10.1093/ijnp/pyu011] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
41 Radke AK, Sneddon EA, Frasier RM, Hopf FW. Recent Perspectives on Sex Differences in Compulsion-Like and Binge Alcohol Drinking. Int J Mol Sci 2021;22:3788. [PMID: 33917517 DOI: 10.3390/ijms22073788] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
42 Barson JR, Leibowitz SF. Orexin/Hypocretin System: Role in Food and Drug Overconsumption. Int Rev Neurobiol 2017;136:199-237. [PMID: 29056152 DOI: 10.1016/bs.irn.2017.06.006] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
43 Tsujino N, Sakurai T. Orexin/hypocretin: a neuropeptide at the interface of sleep, energy homeostasis, and reward system. Pharmacol Rev 2009;61:162-76. [PMID: 19549926 DOI: 10.1124/pr.109.001321] [Cited by in Crossref: 314] [Cited by in F6Publishing: 284] [Article Influence: 26.2] [Reference Citation Analysis]
44 Yang N, Anapindi KDB, Rubakhin SS, Wei P, Yu Q, Li L, Kenny PJ, Sweedler JV. Neuropeptidomics of the Rat Habenular Nuclei. J Proteome Res 2018;17:1463-73. [PMID: 29518334 DOI: 10.1021/acs.jproteome.7b00811] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
45 Castro DC, Berridge KC. Opioid and orexin hedonic hotspots in rat orbitofrontal cortex and insula. Proc Natl Acad Sci U S A 2017;114:E9125-34. [PMID: 29073109 DOI: 10.1073/pnas.1705753114] [Cited by in Crossref: 62] [Cited by in F6Publishing: 52] [Article Influence: 12.4] [Reference Citation Analysis]
46 Plaza-Zabala A, Flores Á, Martín-García E, Saravia R, Maldonado R, Berrendero F. A role for hypocretin/orexin receptor-1 in cue-induced reinstatement of nicotine-seeking behavior. Neuropsychopharmacology 2013;38:1724-36. [PMID: 23518606 DOI: 10.1038/npp.2013.72] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 4.9] [Reference Citation Analysis]
47 Ma P, Liu H, Li H, Huang X, Chen L, Zhai H. Involvement of the insular nitric oxide signaling pathway in the expression of morphine-induced conditioned place preference in rats. Neuroreport 2014;25:641-6. [PMID: 24800987 DOI: 10.1097/WNR.0000000000000146] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
48 Smith RJ, Aston-Jones G. Orexin / hypocretin 1 receptor antagonist reduces heroin self-administration and cue-induced heroin seeking. Eur J Neurosci 2012;35:798-804. [PMID: 22356621 DOI: 10.1111/j.1460-9568.2012.08013.x] [Cited by in Crossref: 74] [Cited by in F6Publishing: 75] [Article Influence: 7.4] [Reference Citation Analysis]
49 Girven KS, Aroni S, Navarrete J, Marino RAM, McKeon PN, Cheer JF, Sparta DR. Glutamatergic input from the insula to the ventral bed nucleus of the stria terminalis controls reward-related behavior. Addict Biol 2021;26:e12961. [PMID: 32820590 DOI: 10.1111/adb.12961] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
50 Juarez B, Han MH. Diversity of Dopaminergic Neural Circuits in Response to Drug Exposure. Neuropsychopharmacology 2016;41:2424-46. [PMID: 26934955 DOI: 10.1038/npp.2016.32] [Cited by in Crossref: 70] [Cited by in F6Publishing: 66] [Article Influence: 11.7] [Reference Citation Analysis]
51 Voorhees CM, Cunningham CL. Involvement of the orexin/hypocretin system in ethanol conditioned place preference. Psychopharmacology (Berl) 2011;214:805-18. [PMID: 21107540 DOI: 10.1007/s00213-010-2082-6] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 3.5] [Reference Citation Analysis]
52 Martin-Fardon R, Boutrel B. Orexin/hypocretin (Orx/Hcrt) transmission and drug-seeking behavior: is the paraventricular nucleus of the thalamus (PVT) part of the drug seeking circuitry? Front Behav Neurosci 2012;6:75. [PMID: 23162448 DOI: 10.3389/fnbeh.2012.00075] [Cited by in Crossref: 53] [Cited by in F6Publishing: 52] [Article Influence: 5.3] [Reference Citation Analysis]
53 Steiner MA, Lecourt H, Jenck F. The dual orexin receptor antagonist almorexant, alone and in combination with morphine, cocaine and amphetamine, on conditioned place preference and locomotor sensitization in the rat. Int J Neuropsychopharmacol 2013;16:417-32. [PMID: 22436395 DOI: 10.1017/S1461145712000193] [Cited by in Crossref: 32] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
54 Raffa RB, Baron S, Bhandal JS, Brown T, Song K, Tallarida CS, Rawls SM. Opioid receptor types involved in the development of nicotine physical dependence in an invertebrate (Planaria) model. Pharmacol Biochem Behav 2013;112:9-14. [PMID: 24084318 DOI: 10.1016/j.pbb.2013.09.012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
55 Lei K, Kwok C, Darevsky D, Wegner SA, Yu J, Nakayama L, Pedrozo V, Anderson L, Ghotra S, Fouad M, Hopf FW. Nucleus Accumbens Shell Orexin-1 Receptors Are Critical Mediators of Binge Intake in Excessive-Drinking Individuals. Front Neurosci 2019;13:88. [PMID: 30814925 DOI: 10.3389/fnins.2019.00088] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
56 Tsujino N, Sakurai T. Role of orexin in modulating arousal, feeding, and motivation. Front Behav Neurosci 2013;7:28. [PMID: 23616752 DOI: 10.3389/fnbeh.2013.00028] [Cited by in Crossref: 135] [Cited by in F6Publishing: 136] [Article Influence: 15.0] [Reference Citation Analysis]
57 Lawrence AJ. Regulation of alcohol-seeking by orexin (hypocretin) neurons. Brain Res 2010;1314:124-9. [PMID: 19646424 DOI: 10.1016/j.brainres.2009.07.072] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 2.3] [Reference Citation Analysis]
58 Fartootzadeh R, Alaei H, Reisi P. Mutual assistance of nucleus accumbens cannabinoid receptor-1 and orexin receptor-2 in response to nicotine: a single-unit study. Res Pharm Sci 2021;16:173-81. [PMID: 34084204 DOI: 10.4103/1735-5362.310524] [Reference Citation Analysis]
59 Abdolahi A, Williams GC, Benesch CG, Wang HZ, Spitzer EM, Scott BE, Block RC, van Wijngaarden E. Damage to the insula leads to decreased nicotine withdrawal during abstinence. Addiction 2015;110:1994-2003. [PMID: 26347067 DOI: 10.1111/add.13061] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 5.9] [Reference Citation Analysis]
60 Jupp B, Krstew E, Dezsi G, Lawrence AJ. Discrete cue-conditioned alcohol-seeking after protracted abstinence: pattern of neural activation and involvement of orexin₁ receptors. Br J Pharmacol 2011;162:880-9. [PMID: 20973776 DOI: 10.1111/j.1476-5381.2010.01088.x] [Cited by in Crossref: 75] [Cited by in F6Publishing: 73] [Article Influence: 6.8] [Reference Citation Analysis]
61 Janes AC, Pizzagalli DA, Richardt S, deB Frederick B, Chuzi S, Pachas G, Culhane MA, Holmes AJ, Fava M, Evins AE, Kaufman MJ. Brain reactivity to smoking cues prior to smoking cessation predicts ability to maintain tobacco abstinence. Biol Psychiatry 2010;67:722-9. [PMID: 20172508 DOI: 10.1016/j.biopsych.2009.12.034] [Cited by in Crossref: 295] [Cited by in F6Publishing: 276] [Article Influence: 24.6] [Reference Citation Analysis]
62 Pasumarthi RK, Fadel J. Stimulation of lateral hypothalamic glutamate and acetylcholine efflux by nicotine: implications for mechanisms of nicotine-induced activation of orexin neurons. J Neurochem 2010;113:1023-35. [PMID: 20236223 DOI: 10.1111/j.1471-4159.2010.06666.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
63 Gorka SM, Phan KL. Orexin modulation of stress reactivity as a novel targeted treatment for anxiety and alcohol use disorder. Neuropsychopharmacology 2021. [PMID: 34341494 DOI: 10.1038/s41386-021-01120-4] [Reference Citation Analysis]
64 Kodadek T, Cai D. Chemistry and biology of orexin signaling. Mol Biosyst 2010;6:1366-75. [PMID: 20532299 DOI: 10.1039/c003468a] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 2.6] [Reference Citation Analysis]
65 Jiang R, Song X, Bali P, Smith A, Bayona CR, Lin L, Cameron MD, McDonald PH, Kenny PJ, Kamenecka TM. Disubstituted piperidines as potent orexin (hypocretin) receptor antagonists. Bioorg Med Chem Lett 2012;22:3890-4. [PMID: 22617492 DOI: 10.1016/j.bmcl.2012.04.122] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
66 Corrigall WA. Hypocretin mechanisms in nicotine addiction: evidence and speculation. Psychopharmacology (Berl) 2009;206:23-37. [PMID: 19529922 DOI: 10.1007/s00213-009-1588-2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
67 Flores Á, Valls-Comamala V, Costa G, Saravia R, Maldonado R, Berrendero F. The hypocretin/orexin system mediates the extinction of fear memories. Neuropsychopharmacology 2014;39:2732-41. [PMID: 24930888 DOI: 10.1038/npp.2014.146] [Cited by in Crossref: 77] [Cited by in F6Publishing: 69] [Article Influence: 9.6] [Reference Citation Analysis]
68 Geste JR, Pompilus M, Febo M, Bruijnzeel AW. Self-administration of the synthetic cathinone MDPV enhances reward function via a nicotinic receptor dependent mechanism. Neuropharmacology 2018;137:286-96. [PMID: 29778945 DOI: 10.1016/j.neuropharm.2018.05.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
69 al'Absi M, Lemieux A, Hodges JS, Allen S. Circulating orexin changes during withdrawal are associated with nicotine craving and risk for smoking relapse. Addict Biol 2019;24:743-53. [PMID: 30117237 DOI: 10.1111/adb.12643] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
70 Fartootzadeh R, Azizi F, Alaei H, Reisi P. Functional crosstalk of nucleus accumbens CB1 and OX2 receptors in response to nicotine-induced place preference. Neurosci Lett 2019;698:160-4. [PMID: 30659912 DOI: 10.1016/j.neulet.2019.01.027] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
71 Loney GC, King CP, Meyer PJ. Systemic nicotine enhances opioid self-administration and modulates the formation of opioid-associated memories partly through actions within the insular cortex. Sci Rep 2021;11:3321. [PMID: 33558613 DOI: 10.1038/s41598-021-81955-5] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
72 Borgland SL, Chang SJ, Bowers MS, Thompson JL, Vittoz N, Floresco SB, Chou J, Chen BT, Bonci A. Orexin A/hypocretin-1 selectively promotes motivation for positive reinforcers. J Neurosci 2009;29:11215-25. [PMID: 19741128 DOI: 10.1523/JNEUROSCI.6096-08.2009] [Cited by in Crossref: 245] [Cited by in F6Publishing: 162] [Article Influence: 18.8] [Reference Citation Analysis]
73 Moorman DE. The hypocretin/orexin system as a target for excessive motivation in alcohol use disorders. Psychopharmacology (Berl) 2018;235:1663-80. [PMID: 29508004 DOI: 10.1007/s00213-018-4871-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
74 Wang W, Pan Y, Li Q, Wang L. Orexin: A potential role in the process of obstructive sleep apnea. Peptides 2013;42:48-54. [DOI: 10.1016/j.peptides.2013.01.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
75 Ibrahim C, Rubin-Kahana DS, Pushparaj A, Musiol M, Blumberger DM, Daskalakis ZJ, Zangen A, Le Foll B. The Insula: A Brain Stimulation Target for the Treatment of Addiction. Front Pharmacol 2019;10:720. [PMID: 31312138 DOI: 10.3389/fphar.2019.00720] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
76 Dehkordi O, Rose JE, Dávila-García MI, Millis RM, Mirzaei SA, Manaye KF, Jayam-Trouth A. Neuroanatomical Relationships between Orexin/Hypocretin-Containing Neurons/Nerve Fibers and Nicotine-Induced c-Fos-Activated Cells of the Reward-Addiction Neurocircuitry. J Alcohol Drug Depend 2017;5:273. [PMID: 29038792 DOI: 10.4172/2329-6488.1000273] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
77 Baimel C, Borgland SL. Hypocretin/Orexin and Plastic Adaptations Associated with Drug Abuse. Curr Top Behav Neurosci 2017;33:283-304. [PMID: 28303403 DOI: 10.1007/7854_2016_44] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
78 Muschamp JW, Hollander JA, Thompson JL, Voren G, Hassinger LC, Onvani S, Kamenecka TM, Borgland SL, Kenny PJ, Carlezon WA. Hypocretin (orexin) facilitates reward by attenuating the antireward effects of its cotransmitter dynorphin in ventral tegmental area. Proceedings of the National Academy of Sciences 2014;111:E1648-55. [DOI: 10.1073/pnas.1315542111] [Cited by in Crossref: 159] [Cited by in F6Publishing: 145] [Article Influence: 19.9] [Reference Citation Analysis]
79 Alijanpour S, Tirgar F, Zarrindast MR. Role of dorsal hippocampal orexin-1 receptors in memory restoration induced by morphine sensitization phenomenon. Neuroscience 2016;312:215-26. [PMID: 26592714 DOI: 10.1016/j.neuroscience.2015.11.023] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
80 Gao XB, Hermes G. Neural plasticity in hypocretin neurons: the basis of hypocretinergic regulation of physiological and behavioral functions in animals. Front Syst Neurosci 2015;9:142. [PMID: 26539086 DOI: 10.3389/fnsys.2015.00142] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
81 Pushparaj A, Hamani C, Yu W, Shin DS, Kang B, Nobrega JN, Le Foll B. Electrical stimulation of the insular region attenuates nicotine-taking and nicotine-seeking behaviors. Neuropsychopharmacology 2013;38:690-8. [PMID: 23249816 DOI: 10.1038/npp.2012.235] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 5.0] [Reference Citation Analysis]
82 Berrendero F, Robledo P, Trigo JM, Martín-García E, Maldonado R. Neurobiological mechanisms involved in nicotine dependence and reward: participation of the endogenous opioid system. Neurosci Biobehav Rev 2010;35:220-31. [PMID: 20170672 DOI: 10.1016/j.neubiorev.2010.02.006] [Cited by in Crossref: 94] [Cited by in F6Publishing: 82] [Article Influence: 7.8] [Reference Citation Analysis]
83 Jupp B, Krivdic B, Krstew E, Lawrence AJ. The orexin1 receptor antagonist SB-334867 dissociates the motivational properties of alcohol and sucrose in rats. Brain Research 2011;1391:54-9. [DOI: 10.1016/j.brainres.2011.03.045] [Cited by in Crossref: 92] [Cited by in F6Publishing: 93] [Article Influence: 8.4] [Reference Citation Analysis]
84 Ch’ng SS, Lawrence AJ. Distribution of the orexin-1 receptor (OX1R) in the mouse forebrain and rostral brainstem: A characterisation of OX1R-eGFP mice. Journal of Chemical Neuroanatomy 2015;66-67:1-9. [DOI: 10.1016/j.jchemneu.2015.03.002] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 5.0] [Reference Citation Analysis]
85 von der Goltz C, Koopmann A, Dinter C, Richter A, Rockenbach C, Grosshans M, Nakovics H, Wiedemann K, Mann K, Winterer G, Kiefer F. Orexin and leptin are associated with nicotine craving: A link between smoking, appetite and reward. Psychoneuroendocrinology 2010;35:570-7. [DOI: 10.1016/j.psyneuen.2009.09.005] [Cited by in Crossref: 58] [Cited by in F6Publishing: 50] [Article Influence: 4.8] [Reference Citation Analysis]
86 Morgan AJ, Harrod SB, Lacy RT, Stanley EM, Fadel JR. Intravenous prenatal nicotine exposure increases orexin expression in the lateral hypothalamus and orexin innervation of the ventral tegmental area in adult male rats. Drug Alcohol Depend 2013;132:562-70. [PMID: 23664126 DOI: 10.1016/j.drugalcdep.2013.04.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
87 Kenny PJ. Emerging therapeutic targets for the treatment of nicotine addiction. Expert Rev Clin Pharmacol 2009;2:221-5. [PMID: 24410700 DOI: 10.1586/ecp.09.6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
88 Aston-Jones G, Smith RJ, Sartor GC, Moorman DE, Massi L, Tahsili-Fahadan P, Richardson KA. Lateral hypothalamic orexin/hypocretin neurons: A role in reward-seeking and addiction. Brain Res 2010;1314:74-90. [PMID: 19815001 DOI: 10.1016/j.brainres.2009.09.106] [Cited by in Crossref: 238] [Cited by in F6Publishing: 242] [Article Influence: 18.3] [Reference Citation Analysis]
89 Kwok C, Lei K, Pedrozo V, Anderson L, Ghotra S, Walsh M, Li L, Yu J, Hopf FW. Differential importance of nucleus accumbens Ox1Rs and AMPARs for female and male mouse binge alcohol drinking. Sci Rep 2021;11:231. [PMID: 33420199 DOI: 10.1038/s41598-020-79935-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
90 Khoo SY, Brown RM. Orexin/hypocretin based pharmacotherapies for the treatment of addiction: DORA or SORA? CNS Drugs 2014;28:713-30. [PMID: 24942635 DOI: 10.1007/s40263-014-0179-x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 6.0] [Reference Citation Analysis]
91 Tuerke KJ, Limebeer CL, Fletcher PJ, Parker LA. Double dissociation between regulation of conditioned disgust and taste avoidance by serotonin availability at the 5-HT(3) receptor in the posterior and anterior insular cortex. J Neurosci 2012;32:13709-17. [PMID: 23035083 DOI: 10.1523/JNEUROSCI.2042-12.2012] [Cited by in Crossref: 45] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
92 España RA, Oleson EB, Locke JL, Brookshire BR, Roberts DC, Jones SR. The hypocretin-orexin system regulates cocaine self-administration via actions on the mesolimbic dopamine system. Eur J Neurosci 2010;31:336-48. [PMID: 20039943 DOI: 10.1111/j.1460-9568.2009.07065.x] [Cited by in Crossref: 165] [Cited by in F6Publishing: 162] [Article Influence: 12.7] [Reference Citation Analysis]
93 Rosenthal DG, Weitzman M, Benowitz NL. Nicotine Addiction: Mechanisms and Consequences. International Journal of Mental Health 2014;40:22-38. [DOI: 10.2753/imh0020-7411400102] [Cited by in Crossref: 5] [Article Influence: 0.6] [Reference Citation Analysis]
94 Hefzy H, Silver RW, Silver B. The no smoking sign--insular infarction. J Neuroimaging 2011;21:e169-70. [PMID: 20609039 DOI: 10.1111/j.1552-6569.2010.00486.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
95 Zhou WL, Gao XB, Picciotto MR. Acetylcholine Acts through Nicotinic Receptors to Enhance the Firing Rate of a Subset of Hypocretin Neurons in the Mouse Hypothalamus through Distinct Presynaptic and Postsynaptic Mechanisms.. eNeuro 2015;2:e0052. [PMID: 26322330 DOI: 10.1523/ENEURO.0052-14.2015] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
96 Ghanemi A, Hu X. Targeting the orexinergic system: Mainly but not only for sleep-wakefulness therapies. Alexandria Journal of Medicine 2015;51:279-86. [DOI: 10.1016/j.ajme.2014.07.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
97 García-Brito S, Aldavert-Vera L, Huguet G, Kádár E, Segura-Torres P. Orexin-1 receptor blockade differentially affects spatial and visual discrimination memory facilitation by intracranial self-stimulation. Neurobiol Learn Mem 2020;169:107188. [PMID: 32061874 DOI: 10.1016/j.nlm.2020.107188] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
98 Gozzi A, Turrini G, Piccoli L, Massagrande M, Amantini D, Antolini M, Martinelli P, Cesari N, Montanari D, Tessari M, Corsi M, Bifone A. Functional magnetic resonance imaging reveals different neural substrates for the effects of orexin-1 and orexin-2 receptor antagonists. PLoS One 2011;6:e16406. [PMID: 21307957 DOI: 10.1371/journal.pone.0016406] [Cited by in Crossref: 76] [Cited by in F6Publishing: 75] [Article Influence: 6.9] [Reference Citation Analysis]
99 Hopf FW. Recent perspectives on orexin/hypocretin promotion of addiction-related behaviors. Neuropharmacology 2020;168:108013. [PMID: 32092435 DOI: 10.1016/j.neuropharm.2020.108013] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 9.5] [Reference Citation Analysis]
100 Sharf R, Sarhan M, Brayton CE, Guarnieri DJ, Taylor JR, DiLeone RJ. Orexin signaling via the orexin 1 receptor mediates operant responding for food reinforcement. Biol Psychiatry 2010;67:753-60. [PMID: 20189166 DOI: 10.1016/j.biopsych.2009.12.035] [Cited by in Crossref: 74] [Cited by in F6Publishing: 71] [Article Influence: 6.2] [Reference Citation Analysis]
101 Korpi ER, den Hollander B, Farooq U, Vashchinkina E, Rajkumar R, Nutt DJ, Hyytiä P, Dawe GS, Koulu M. Mechanisms of Action and Persistent Neuroplasticity by Drugs of Abuse. Pharmacol Rev 2015;67:872-1004. [DOI: 10.1124/pr.115.010967] [Cited by in Crossref: 82] [Cited by in F6Publishing: 74] [Article Influence: 11.7] [Reference Citation Analysis]
102 Zhou L, Smith RJ, Do PH, Aston-Jones G, See RE. Repeated orexin 1 receptor antagonism effects on cocaine seeking in rats. Neuropharmacology 2012;63:1201-7. [PMID: 22971541 DOI: 10.1016/j.neuropharm.2012.07.044] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
103 Moerke MJ, McMahon LR, Wilkerson JL. More than Smoke and Patches: The Quest for Pharmacotherapies to Treat Tobacco Use Disorder. Pharmacol Rev 2020;72:527-57. [PMID: 32205338 DOI: 10.1124/pr.119.018028] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
104 Changeux JP. Nicotine addiction and nicotinic receptors: lessons from genetically modified mice. Nat Rev Neurosci 2010;11:389-401. [PMID: 20485364 DOI: 10.1038/nrn2849] [Cited by in Crossref: 287] [Cited by in F6Publishing: 281] [Article Influence: 23.9] [Reference Citation Analysis]
105 Matzeu A, Martin-fardon R. Understanding the Role of Orexin Neuropeptides in Drug Addiction: Preclinical Studies and Translational Value. Front Behav Neurosci 2022;15:787595. [DOI: 10.3389/fnbeh.2021.787595] [Reference Citation Analysis]
106 Sakurai T. The role of orexin in motivated behaviours. Nat Rev Neurosci 2014;15:719-31. [DOI: 10.1038/nrn3837] [Cited by in Crossref: 244] [Cited by in F6Publishing: 221] [Article Influence: 30.5] [Reference Citation Analysis]
107 Facciolo RM, Crudo M, Zizza M, Giusi G, Canonaco M. Feeding behaviors and ORXR–β-GABAAR subunit interactions in Carassius auratus. Neurotoxicology and Teratology 2011;33:641-50. [DOI: 10.1016/j.ntt.2011.09.008] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.4] [Reference Citation Analysis]
108 Plaza-Zabala A, Martín-García E, de Lecea L, Maldonado R, Berrendero F. Hypocretins regulate the anxiogenic-like effects of nicotine and induce reinstatement of nicotine-seeking behavior. J Neurosci 2010;30:2300-10. [PMID: 20147556 DOI: 10.1523/JNEUROSCI.5724-09.2010] [Cited by in Crossref: 124] [Cited by in F6Publishing: 81] [Article Influence: 10.3] [Reference Citation Analysis]
109 Wang C, Wang Q, Ji B, Pan Y, Xu C, Cheng B, Bai B, Chen J. The Orexin/Receptor System: Molecular Mechanism and Therapeutic Potential for Neurological Diseases. Front Mol Neurosci 2018;11:220. [PMID: 30002617 DOI: 10.3389/fnmol.2018.00220] [Cited by in Crossref: 55] [Cited by in F6Publishing: 53] [Article Influence: 13.8] [Reference Citation Analysis]
110 Smith RJ, See RE, Aston-Jones G. Orexin/hypocretin signaling at the orexin 1 receptor regulates cue-elicited cocaine-seeking. Eur J Neurosci 2009;30:493-503. [PMID: 19656173 DOI: 10.1111/j.1460-9568.2009.06844.x] [Cited by in Crossref: 157] [Cited by in F6Publishing: 151] [Article Influence: 12.1] [Reference Citation Analysis]
111 Centanni SW, Janes AC, Haggerty DL, Atwood B, Hopf FW. Better living through understanding the insula: Why subregions can make all the difference. Neuropharmacology 2021;198:108765. [PMID: 34461066 DOI: 10.1016/j.neuropharm.2021.108765] [Reference Citation Analysis]
112 Boutrel B, Steiner N, Halfon O. The hypocretins and the reward function: what have we learned so far? Front Behav Neurosci 2013;7:59. [PMID: 23781178 DOI: 10.3389/fnbeh.2013.00059] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 3.6] [Reference Citation Analysis]
113 Shoblock JR, Welty N, Aluisio L, Fraser I, Motley ST, Morton K, Palmer J, Bonaventure P, Carruthers NI, Lovenberg TW, Boggs J, Galici R. Selective blockade of the orexin-2 receptor attenuates ethanol self-administration, place preference, and reinstatement. Psychopharmacology 2011;215:191-203. [DOI: 10.1007/s00213-010-2127-x] [Cited by in Crossref: 99] [Cited by in F6Publishing: 102] [Article Influence: 8.3] [Reference Citation Analysis]
114 Abdolahi A, Acosta G, Breslin FJ, Hemby SE, Lynch WJ. Incubation of nicotine seeking is associated with enhanced protein kinase A-regulated signaling of dopamine- and cAMP-regulated phosphoprotein of 32 kDa in the insular cortex. Eur J Neurosci 2010;31:733-41. [PMID: 20384816 DOI: 10.1111/j.1460-9568.2010.07114.x] [Cited by in Crossref: 76] [Cited by in F6Publishing: 75] [Article Influence: 6.3] [Reference Citation Analysis]
115 Jaramillo AA, Randall PA, Frisbee S, Besheer J. Modulation of sensitivity to alcohol by cortical and thalamic brain regions. Eur J Neurosci 2016;44:2569-80. [PMID: 27543844 DOI: 10.1111/ejn.13374] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 4.7] [Reference Citation Analysis]
116 Forray A, Sofuoglu M. Future pharmacological treatments for substance use disorders. Br J Clin Pharmacol 2014;77:382-400. [PMID: 23039267 DOI: 10.1111/j.1365-2125.2012.04474.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 4.5] [Reference Citation Analysis]
117 Piccoli L, Micioni Di Bonaventura MV, Cifani C, Costantini VJ, Massagrande M, Montanari D, Martinelli P, Antolini M, Ciccocioppo R, Massi M, Merlo-Pich E, Di Fabio R, Corsi M. Role of orexin-1 receptor mechanisms on compulsive food consumption in a model of binge eating in female rats. Neuropsychopharmacology 2012;37:1999-2011. [PMID: 22569505 DOI: 10.1038/npp.2012.48] [Cited by in Crossref: 86] [Cited by in F6Publishing: 84] [Article Influence: 8.6] [Reference Citation Analysis]
118 Seo D, Jia Z, Lacadie CM, Tsou KA, Bergquist K, Sinha R. Sex differences in neural responses to stress and alcohol context cues. Hum Brain Mapp 2011;32:1998-2013. [PMID: 21162046 DOI: 10.1002/hbm.21165] [Cited by in Crossref: 97] [Cited by in F6Publishing: 94] [Article Influence: 8.1] [Reference Citation Analysis]
119 Stoker AK, Markou A. Neurobiological Bases of Cue- and Nicotine-induced Reinstatement of Nicotine Seeking: Implications for the Development of Smoking Cessation Medications. Curr Top Behav Neurosci 2015;24:125-54. [PMID: 25638336 DOI: 10.1007/978-3-319-13482-6_5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
120 Plaza-Zabala A, Flores Á, Maldonado R, Berrendero F. Hypocretin/orexin signaling in the hypothalamic paraventricular nucleus is essential for the expression of nicotine withdrawal. Biol Psychiatry 2012;71:214-23. [PMID: 21831361 DOI: 10.1016/j.biopsych.2011.06.025] [Cited by in Crossref: 60] [Cited by in F6Publishing: 59] [Article Influence: 5.5] [Reference Citation Analysis]
121 Artiges E, Ricalens E, Berthoz S, Krebs MO, Penttilä J, Trichard C, Martinot JL. Exposure to smoking cues during an emotion recognition task can modulate limbic fMRI activation in cigarette smokers. Addict Biol 2009;14:469-77. [PMID: 19650816 DOI: 10.1111/j.1369-1600.2009.00167.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
122 Lei K, Wegner SA, Yu JH, Mototake A, Hu B, Hopf FW. Nucleus Accumbens Shell and mPFC but Not Insula Orexin-1 Receptors Promote Excessive Alcohol Drinking. Front Neurosci 2016;10:400. [PMID: 27625592 DOI: 10.3389/fnins.2016.00400] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 3.7] [Reference Citation Analysis]
123 Martin-Fardon R, Zorrilla EP, Ciccocioppo R, Weiss F. Role of innate and drug-induced dysregulation of brain stress and arousal systems in addiction: Focus on corticotropin-releasing factor, nociceptin/orphanin FQ, and orexin/hypocretin. Brain Res 2010;1314:145-61. [PMID: 20026088 DOI: 10.1016/j.brainres.2009.12.027] [Cited by in Crossref: 75] [Cited by in F6Publishing: 73] [Article Influence: 5.8] [Reference Citation Analysis]
124 Jackson KJ, Muldoon PP, De Biasi M, Damaj MI. New mechanisms and perspectives in nicotine withdrawal. Neuropharmacology 2015;96:223-34. [PMID: 25433149 DOI: 10.1016/j.neuropharm.2014.11.009] [Cited by in Crossref: 56] [Cited by in F6Publishing: 47] [Article Influence: 7.0] [Reference Citation Analysis]
125 Le Foll B, Pushparaj A, Pryslawsky Y, Forget B, Vemuri K, Makriyannis A, Trigo JM. Translational strategies for therapeutic development in nicotine addiction: rethinking the conventional bench to bedside approach. Prog Neuropsychopharmacol Biol Psychiatry 2014;52:86-93. [PMID: 24140878 DOI: 10.1016/j.pnpbp.2013.10.009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
126 Xue YX, Deng JH, Chen YY, Zhang LB, Wu P, Huang GD, Luo YX, Bao YP, Wang YM, Shaham Y, Shi J, Lu L. Effect of Selective Inhibition of Reactivated Nicotine-Associated Memories With Propranolol on Nicotine Craving. JAMA Psychiatry 2017;74:224-32. [PMID: 28146250 DOI: 10.1001/jamapsychiatry.2016.3907] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 8.2] [Reference Citation Analysis]
127 Meng Z, Liu C, Hu X, Ma Y. Somatosensory cortices are required for the acquisition of morphine-induced conditioned place preference. PLoS One 2009;4:e7742. [PMID: 19888465 DOI: 10.1371/journal.pone.0007742] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
128 James MH, Mahler SV, Moorman DE, Aston-Jones G. A Decade of Orexin/Hypocretin and Addiction: Where Are We Now? Curr Top Behav Neurosci 2017;33:247-81. [PMID: 28012090 DOI: 10.1007/7854_2016_57] [Cited by in Crossref: 80] [Cited by in F6Publishing: 76] [Article Influence: 16.0] [Reference Citation Analysis]
129 Gillman AG, Leffel JK, Kosobud AE, Timberlake W. Behavioral characteristics and pharmacological manipulations of a nicotine-entrainable circadian oscillator. Chronobiol Int 2013;30:855-69. [PMID: 23697901 DOI: 10.3109/07420528.2013.782314] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
130 Iyer M, Essner RA, Klingenberg B, Carter ME. Identification of discrete, intermingled hypocretin neuronal populations. J Comp Neurol 2018;526:2937-54. [PMID: 30019757 DOI: 10.1002/cne.24490] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
131 Matzeu A, Martin-Fardon R. Drug Seeking and Relapse: New Evidence of a Role for Orexin and Dynorphin Co-transmission in the Paraventricular Nucleus of the Thalamus. Front Neurol 2018;9:720. [PMID: 30210441 DOI: 10.3389/fneur.2018.00720] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
132 Tuesta LM, Fowler CD, Kenny PJ. Recent advances in understanding nicotinic receptor signaling mechanisms that regulate drug self-administration behavior. Biochem Pharmacol 2011;82:984-95. [PMID: 21740894 DOI: 10.1016/j.bcp.2011.06.026] [Cited by in Crossref: 81] [Cited by in F6Publishing: 73] [Article Influence: 7.4] [Reference Citation Analysis]
133 Li CL, Zhu N, Meng XL, Li YH, Sui N. Effects of inactivating the agranular or granular insular cortex on the acquisition of the morphine-induced conditioned place preference and naloxone-precipitated conditioned place aversion in rats. J Psychopharmacol 2013;27:837-44. [PMID: 23784741 DOI: 10.1177/0269881113492028] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 3.4] [Reference Citation Analysis]
134 Thompson JL, Borgland SL. A role for hypocretin/orexin in motivation. Behav Brain Res 2011;217:446-53. [PMID: 20920531 DOI: 10.1016/j.bbr.2010.09.028] [Cited by in Crossref: 68] [Cited by in F6Publishing: 74] [Article Influence: 6.2] [Reference Citation Analysis]
135 Sun YM, Chen RX, Li ZF, Spijker S, Zhai RW, Yang SC. The caudal part of the posterior insula of rats participates in the maintenance but not the acquisition of morphine conditioned place preference. CNS Neurosci Ther 2018;24:420-8. [PMID: 29318747 DOI: 10.1111/cns.12799] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
136 Naqvi NH, Gaznick N, Tranel D, Bechara A. The insula: a critical neural substrate for craving and drug seeking under conflict and risk. Ann N Y Acad Sci 2014;1316:53-70. [PMID: 24690001 DOI: 10.1111/nyas.12415] [Cited by in Crossref: 184] [Cited by in F6Publishing: 174] [Article Influence: 23.0] [Reference Citation Analysis]
137 Sharf R, Sarhan M, Dileone RJ. Role of orexin/hypocretin in dependence and addiction. Brain Res 2010;1314:130-8. [PMID: 19699189 DOI: 10.1016/j.brainres.2009.08.028] [Cited by in Crossref: 73] [Cited by in F6Publishing: 72] [Article Influence: 5.6] [Reference Citation Analysis]
138 Ma H, Wang N, Wang X, Jia M, Li Y, Cui C. Wnt7a in Mouse Insular Cortex Contributes to Anxiety-like Behavior During Protracted Abstinence from Morphine. Neuroscience 2018;394:164-76. [PMID: 30367944 DOI: 10.1016/j.neuroscience.2018.10.032] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
139 Li SB, de Lecea L. The hypocretin (orexin) system: from a neural circuitry perspective. Neuropharmacology 2020;167:107993. [PMID: 32135427 DOI: 10.1016/j.neuropharm.2020.107993] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 14.5] [Reference Citation Analysis]
140 Yan J, He C, Xia JX, Zhang D, Hu ZA. Orexin-A excites pyramidal neurons in layer 2/3 of the rat prefrontal cortex. Neurosci Lett 2012;520:92-7. [PMID: 22617634 DOI: 10.1016/j.neulet.2012.05.038] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
141 Contreras M, Billeke P, Vicencio S, Madrid C, Perdomo G, González M, Torrealba F. A role for the insular cortex in long-term memory for context-evoked drug craving in rats. Neuropsychopharmacology 2012;37:2101-8. [PMID: 22534623 DOI: 10.1038/npp.2012.59] [Cited by in Crossref: 55] [Cited by in F6Publishing: 53] [Article Influence: 5.5] [Reference Citation Analysis]
142 Gao XB, Horvath TL. From molecule to behavior: hypocretin/orexin revisited from a sex-dependent perspective. Endocr Rev 2021:bnab042. [PMID: 34792130 DOI: 10.1210/endrev/bnab042] [Reference Citation Analysis]
143 Forget B, Pushparaj A, Le Foll B. Granular insular cortex inactivation as a novel therapeutic strategy for nicotine addiction. Biol Psychiatry 2010;68:265-71. [PMID: 20299008 DOI: 10.1016/j.biopsych.2010.01.029] [Cited by in Crossref: 108] [Cited by in F6Publishing: 104] [Article Influence: 9.0] [Reference Citation Analysis]
144 Morganstern I, Barson JR, Leibowitz SF. Regulation of drug and palatable food overconsumption by similar peptide systems. Curr Drug Abuse Rev 2011;4:163-73. [PMID: 21999690 DOI: 10.2174/1874473711104030163] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 2.7] [Reference Citation Analysis]
145 Schmeichel BE, Matzeu A, Koebel P, Vendruscolo LF, Sidhu H, Shahryari R, Kieffer BL, Koob GF, Martin-Fardon R, Contet C. Knockdown of hypocretin attenuates extended access of cocaine self-administration in rats. Neuropsychopharmacology 2018;43:2373-82. [PMID: 29703996 DOI: 10.1038/s41386-018-0054-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
146 Khoo SY, Gibson GD, Prasad AA, McNally GP. How contexts promote and prevent relapse to drug seeking. Genes Brain Behav 2017;16:185-204. [PMID: 27612655 DOI: 10.1111/gbb.12328] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 4.2] [Reference Citation Analysis]
147 Milella MS, Passarelli F, De Carolis L, Schepisi C, Nativio P, Scaccianoce S, Nencini P. Opposite roles of dopamine and orexin in quinpirole-induced excessive drinking: a rat model of psychotic polydipsia. Psychopharmacology 2010;211:355-66. [DOI: 10.1007/s00213-010-1909-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
148 Zhang R, Jia W, Wang Y, Zhu Y, Liu F, Li B, Liu F, Wang H, Tan Q. A glutamatergic insular-striatal projection regulates the reinstatement of cue-associated morphine-seeking behavior in mice. Brain Res Bull 2019;152:257-64. [PMID: 31351159 DOI: 10.1016/j.brainresbull.2019.07.023] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
149 Huang H, Xu Y, van den Pol AN. Nicotine excites hypothalamic arcuate anorexigenic proopiomelanocortin neurons and orexigenic neuropeptide Y neurons: similarities and differences. J Neurophysiol 2011;106:1191-202. [PMID: 21653710 DOI: 10.1152/jn.00740.2010] [Cited by in Crossref: 44] [Cited by in F6Publishing: 49] [Article Influence: 4.0] [Reference Citation Analysis]
150 Kim JS, Martin-Fardon R. Possible Role of CRF-Hcrt Interaction in the Infralimbic Cortex in the Emergence and Maintenance of Compulsive Alcohol-Seeking Behavior. Alcohol Clin Exp Res 2020;44:354-67. [PMID: 31840823 DOI: 10.1111/acer.14264] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
151 Zarrabian S, Riahi E, Karimi S, Razavi Y, Haghparast A. The potential role of the orexin reward system in future treatments for opioid drug abuse. Brain Research 2020;1731:146028. [DOI: 10.1016/j.brainres.2018.11.023] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
152 Koesema E, Kodadek T. Global analysis of gene expression mediated by OX1 orexin receptor signaling in a hypothalamic cell line. PLoS One 2017;12:e0188082. [PMID: 29145494 DOI: 10.1371/journal.pone.0188082] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
153 España RA. Hypocretin/orexin involvement in reward and reinforcement. Vitam Horm 2012;89:185-208. [PMID: 22640614 DOI: 10.1016/B978-0-12-394623-2.00010-X] [Cited by in Crossref: 21] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
154 Flores A, Maldonado R, Berrendero F. Cannabinoid-hypocretin cross-talk in the central nervous system: what we know so far. Front Neurosci 2013;7:256. [PMID: 24391536 DOI: 10.3389/fnins.2013.00256] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 3.9] [Reference Citation Analysis]
155 Uslaner JM, Winrow CJ, Gotter AL, Roecker AJ, Coleman PJ, Hutson PH, Le AD, Renger JJ. Selective orexin 2 receptor antagonism blocks cue-induced reinstatement, but not nicotine self-administration or nicotine-induced reinstatement. Behav Brain Res 2014;269:61-5. [PMID: 24746488 DOI: 10.1016/j.bbr.2014.04.012] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
156 Nagase H, Yamamoto N, Yata M, Ohrui S, Okada T, Saitoh T, Kutsumura N, Nagumo Y, Irukayama-tomobe Y, Ishikawa Y, Ogawa Y, Hirayama S, Kuroda D, Watanabe Y, Gouda H, Yanagisawa M. Design and Synthesis of Potent and Highly Selective Orexin 1 Receptor Antagonists with a Morphinan Skeleton and Their Pharmacologies. J Med Chem 2017;60:1018-40. [DOI: 10.1021/acs.jmedchem.6b01418] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
157 Nall RW, Heinsbroek JA, Nentwig TB, Kalivas PW, Bobadilla AC. Circuit selectivity in drug versus natural reward seeking behaviors. J Neurochem 2021;157:1450-72. [PMID: 33420731 DOI: 10.1111/jnc.15297] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
158 Kusumoto-Yoshida I, Liu H, Chen BT, Fontanini A, Bonci A. Central role for the insular cortex in mediating conditioned responses to anticipatory cues. Proc Natl Acad Sci U S A 2015;112:1190-5. [PMID: 25583486 DOI: 10.1073/pnas.1416573112] [Cited by in Crossref: 63] [Cited by in F6Publishing: 45] [Article Influence: 9.0] [Reference Citation Analysis]
159 Plaza-Zabala A, Maldonado R, Berrendero F. The hypocretin/orexin system: implications for drug reward and relapse. Mol Neurobiol 2012;45:424-39. [PMID: 22430644 DOI: 10.1007/s12035-012-8255-z] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 3.5] [Reference Citation Analysis]
160 LeSage MG, Perry JL, Kotz CM, Shelley D, Corrigall WA. Nicotine self-administration in the rat: effects of hypocretin antagonists and changes in hypocretin mRNA. Psychopharmacology (Berl) 2010;209:203-12. [PMID: 20177882 DOI: 10.1007/s00213-010-1792-0] [Cited by in Crossref: 64] [Cited by in F6Publishing: 62] [Article Influence: 5.3] [Reference Citation Analysis]
161 Borgland SL, Ungless MA, Bonci A. Convergent actions of orexin/hypocretin and CRF on dopamine neurons: Emerging players in addiction. Brain Res 2010;1314:139-44. [PMID: 19891960 DOI: 10.1016/j.brainres.2009.10.068] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 3.8] [Reference Citation Analysis]
162 Seoane-Collazo P, Diéguez C, Nogueiras R, Rahmouni K, Fernández-Real JM, López M. Nicotine' actions on energy balance: Friend or foe? Pharmacol Ther 2021;219:107693. [PMID: 32987056 DOI: 10.1016/j.pharmthera.2020.107693] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
163 Lebold TP, Bonaventure P, Shireman BT. Selective orexin receptor antagonists. Bioorg Med Chem Lett 2013;23:4761-9. [PMID: 23891187 DOI: 10.1016/j.bmcl.2013.06.057] [Cited by in Crossref: 53] [Cited by in F6Publishing: 47] [Article Influence: 5.9] [Reference Citation Analysis]
164 Khoo SY, Clemens KJ, Mcnally GP. Palatable food self-administration and reinstatement are not affected by dual orexin receptor antagonism. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2018;87:147-57. [DOI: 10.1016/j.pnpbp.2017.06.028] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
165 Matzeu A, Zamora-Martinez ER, Martin-Fardon R. The paraventricular nucleus of the thalamus is recruited by both natural rewards and drugs of abuse: recent evidence of a pivotal role for orexin/hypocretin signaling in this thalamic nucleus in drug-seeking behavior. Front Behav Neurosci 2014;8:117. [PMID: 24765071 DOI: 10.3389/fnbeh.2014.00117] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 6.1] [Reference Citation Analysis]
166 Barateau L, Jaussent I, Lopez R, Boutrel B, Leu-Semenescu S, Arnulf I, Dauvilliers Y. Smoking, Alcohol, Drug Use, Abuse and Dependence in Narcolepsy and Idiopathic Hypersomnia: A Case-Control Study. Sleep 2016;39:573-80. [PMID: 26564129 DOI: 10.5665/sleep.5530] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
167 Lei K, Kwok C, Hopf FW. Nucleus accumbens shell Orexin-1 receptors are not needed for single-bottle limited daily access alcohol intake in C57BL/6 mice. Alcohol 2020;89:139-46. [PMID: 32987129 DOI: 10.1016/j.alcohol.2020.09.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
168 Hagar JM, Macht VA, Wilson SP, Fadel JR. Upregulation of orexin/hypocretin expression in aged rats: Effects on feeding latency and neurotransmission in the insular cortex. Neuroscience 2017;350:124-32. [PMID: 28344067 DOI: 10.1016/j.neuroscience.2017.03.021] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
169 Calipari ES, España RA. Hypocretin/orexin regulation of dopamine signaling: implications for reward and reinforcement mechanisms. Front Behav Neurosci 2012;6:54. [PMID: 22933994 DOI: 10.3389/fnbeh.2012.00054] [Cited by in Crossref: 36] [Cited by in F6Publishing: 41] [Article Influence: 3.6] [Reference Citation Analysis]
170 Hrabovszky E, Molnár CS, Borsay BÁ, Gergely P, Herczeg L, Liposits Z. Orexinergic input to dopaminergic neurons of the human ventral tegmental area. PLoS One 2013;8:e83029. [PMID: 24376626 DOI: 10.1371/journal.pone.0083029] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
171 Rappas M, Ali AAE, Bennett KA, Brown JD, Bucknell SJ, Congreve M, Cooke RM, Cseke G, de Graaf C, Doré AS, Errey JC, Jazayeri A, Marshall FH, Mason JS, Mould R, Patel JC, Tehan BG, Weir M, Christopher JA. Comparison of Orexin 1 and Orexin 2 Ligand Binding Modes Using X-ray Crystallography and Computational Analysis. J Med Chem 2020;63:1528-43. [PMID: 31860301 DOI: 10.1021/acs.jmedchem.9b01787] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
172 Kutlu MG, Burke D, Slade S, Hall BJ, Rose JE, Levin ED. Role of insular cortex D₁ and D₂ dopamine receptors in nicotine self-administration in rats. Behav Brain Res 2013;256:273-8. [PMID: 23948214 DOI: 10.1016/j.bbr.2013.08.005] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.9] [Reference Citation Analysis]
173 von der Goltz C, Koopmann A, Dinter C, Richter A, Grosshans M, Fink T, Wiedemann K, Kiefer F. Involvement of orexin in the regulation of stress, depression and reward in alcohol dependence. Horm Behav 2011;60:644-50. [PMID: 21945150 DOI: 10.1016/j.yhbeh.2011.08.017] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 3.6] [Reference Citation Analysis]
174 Baimel C, Borgland SL, Corrigall W. Cocaine and Nicotine Research Illustrates a Range of Hypocretin Mechanisms in Addiction. Sleep Hormones. Elsevier; 2012. pp. 291-313. [DOI: 10.1016/b978-0-12-394623-2.00016-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
175 Scammell TE, Winrow CJ. Orexin receptors: pharmacology and therapeutic opportunities. Annu Rev Pharmacol Toxicol 2011;51:243-66. [PMID: 21034217 DOI: 10.1146/annurev-pharmtox-010510-100528] [Cited by in Crossref: 202] [Cited by in F6Publishing: 194] [Article Influence: 18.4] [Reference Citation Analysis]
176 Lee J, Reddy MM, Kodadek T. Discovery Of An Orexin Receptor Positive Potentiator. Chem Sci 2010;1. [PMID: 24409338 DOI: 10.1039/C0SC00197J] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
177 Flores Á, Maldonado R, Berrendero F. The hypocretin/orexin receptor-1 as a novel target to modulate cannabinoid reward. Biol Psychiatry 2014;75:499-507. [PMID: 23896204 DOI: 10.1016/j.biopsych.2013.06.012] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
178 Li Y, Li S, Wei C, Wang H, Sui N, Kirouac GJ. Orexins in the paraventricular nucleus of the thalamus mediate anxiety-like responses in rats. Psychopharmacology (Berl) 2010;212:251-65. [PMID: 20645079 DOI: 10.1007/s00213-010-1948-y] [Cited by in Crossref: 113] [Cited by in F6Publishing: 113] [Article Influence: 9.4] [Reference Citation Analysis]
179 Brown RM, Khoo SY, Lawrence AJ. Central orexin (hypocretin) 2 receptor antagonism reduces ethanol self-administration, but not cue-conditioned ethanol-seeking, in ethanol-preferring rats. International Journal of Neuropsychopharmacology 2013;16:2067-79. [DOI: 10.1017/s1461145713000333] [Cited by in Crossref: 66] [Cited by in F6Publishing: 40] [Article Influence: 7.3] [Reference Citation Analysis]
180 Oliveira-Maia AJ, de Araujo IE, Monteiro C, Workman V, Galhardo V, Nicolelis MA. The insular cortex controls food preferences independently of taste receptor signaling. Front Syst Neurosci 2012;6:5. [PMID: 22403530 DOI: 10.3389/fnsys.2012.00005] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
181 Campling BG, Collins BN, Algazy KM, Schnoll RA, Lam M. Spontaneous smoking cessation before lung cancer diagnosis. J Thorac Oncol 2011;6:517-24. [PMID: 21258255 DOI: 10.1097/JTO.0b013e318208c7da] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
182 Hata T, Chen J, Ebihara K, Date Y, Ishida Y, Nakahara D. Intra-ventral tegmental area or intracerebroventricular orexin-A increases the intra-cranial self-stimulation threshold via activation of the corticotropin-releasing factor system in rats. Eur J Neurosci 2011;34:816-26. [PMID: 21848921 DOI: 10.1111/j.1460-9568.2011.07808.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
183 Xu T, Yang Y, Ward R, Gao L, Liu Y. Orexin receptors: Multi-functional therapeutic targets for sleeping disorders, eating disorders, drug addiction, cancers and other physiological disorders. Cellular Signalling 2013;25:2413-23. [DOI: 10.1016/j.cellsig.2013.07.025] [Cited by in Crossref: 68] [Cited by in F6Publishing: 65] [Article Influence: 7.6] [Reference Citation Analysis]
184 Yeoh JW, James MH, Jobling P, Bains JS, Graham BA, Dayas CV. Cocaine potentiates excitatory drive in the perifornical/lateral hypothalamus. J Physiol 2012;590:3677-89. [PMID: 22641785 DOI: 10.1113/jphysiol.2012.230268] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 3.8] [Reference Citation Analysis]
185 [DOI: 10.1101/2020.04.25.061887] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
186 Sartor GC, Aston-Jones G. Regulation of the ventral tegmental area by the bed nucleus of the stria terminalis is required for expression of cocaine preference. Eur J Neurosci 2012;36:3549-58. [PMID: 23039920 DOI: 10.1111/j.1460-9568.2012.08277.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 2.9] [Reference Citation Analysis]
187 Hamidovic A. Dual Orexin Receptor Antagonists (DORAs) as an Adjunct Treatment for Smoking Cessation. CNS Drugs 2022. [PMID: 35451800 DOI: 10.1007/s40263-022-00918-0] [Reference Citation Analysis]
188 Pushparaj A, Le Foll B. Involvement of the caudal granular insular cortex in alcohol self-administration in rats. Behavioural Brain Research 2015;293:203-7. [DOI: 10.1016/j.bbr.2015.07.044] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
189 Anderson RI, Moorman DE, Becker HC. Contribution of Dynorphin and Orexin Neuropeptide Systems to the Motivational Effects of Alcohol. Handb Exp Pharmacol 2018;248:473-503. [PMID: 29526023 DOI: 10.1007/164_2018_100] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
190 Riday TT, Fish EW, Robinson JE, Jarrett TM, McGuigan MM, Malanga CJ. Orexin-1 receptor antagonism does not reduce the rewarding potency of cocaine in Swiss-Webster mice. Brain Res 2012;1431:53-61. [PMID: 22133306 DOI: 10.1016/j.brainres.2011.11.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
191 Usui M, Kaneko K, Oi Y, Kobayashi M. Orexin facilitates GABAergic IPSCs via postsynaptic OX1 receptors coupling to the intracellular PKC signalling cascade in the rat cerebral cortex. Neuropharmacology 2019;149:97-112. [PMID: 30763655 DOI: 10.1016/j.neuropharm.2019.02.012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
192 Cera N, Tartaro A, Sensi SL. Modafinil alters intrinsic functional connectivity of the right posterior insula: a pharmacological resting state fMRI study. PLoS One 2014;9:e107145. [PMID: 25237810 DOI: 10.1371/journal.pone.0107145] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
193 Steiner N, Rossetti C, Sakurai T, Yanagisawa M, de Lecea L, Magistretti PJ, Halfon O, Boutrel B. Hypocretin/orexin deficiency decreases cocaine abuse liability. Neuropharmacology 2018;133:395-403. [PMID: 29454841 DOI: 10.1016/j.neuropharm.2018.02.010] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
194 Vlachou S, Markou A. Intracranial Self-Stimulation. In: Olmstead MC, editor. Animal Models of Drug Addiction. Totowa: Humana Press; 2011. pp. 3-56. [DOI: 10.1007/978-1-60761-934-5_1] [Cited by in Crossref: 22] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
195 James MH, Charnley JL, Levi EM, Jones E, Yeoh JW, Smith DW, Dayas CV. Orexin-1 receptor signalling within the ventral tegmental area, but not the paraventricular thalamus, is critical to regulating cue-induced reinstatement of cocaine-seeking. Int J Neuropsychopharmacol 2011;14:684-90. [PMID: 21447232 DOI: 10.1017/S1461145711000423] [Cited by in Crossref: 89] [Cited by in F6Publishing: 62] [Article Influence: 8.1] [Reference Citation Analysis]
196 Bruijnzeel AW. Neuropeptide systems and new treatments for nicotine addiction. Psychopharmacology (Berl) 2017;234:1419-37. [PMID: 28028605 DOI: 10.1007/s00213-016-4513-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
197 Zhou L, Sun WL, See RE. Orexin Receptor Targets for Anti-Relapse Medication Development in Drug Addiction. Pharmaceuticals (Basel) 2011;4:804-21. [PMID: 23997653 DOI: 10.3390/ph4060804] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
198 Pushparaj A, Kim AS, Musiol M, Zangen A, Daskalakis ZJ, Zack M, Winstanley CA, Le Foll B. Differential Involvement of the Agranular vs Granular Insular Cortex in the Acquisition and Performance of Choice Behavior in a Rodent Gambling Task. Neuropsychopharmacology 2015;40:2832-42. [PMID: 25953358 DOI: 10.1038/npp.2015.133] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.9] [Reference Citation Analysis]
199 Bozinoff N, Le Foll B. Understanding the implications of the biobehavioral basis of nicotine addiction and its impact on the efficacy of treatment. Expert Rev Respir Med 2018;12:793-804. [PMID: 30092681 DOI: 10.1080/17476348.2018.1507736] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]